Related Experiment Video
Updated: Jul 13, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
BRCA1 activates a G2-M cell cycle checkpoint following 6-thioguanine-induced DNA mismatch damage
Kazuhiko Yamane1, Jane E Schupp, Timothy J Kinsella
1Department of Radiation Oncology, Case Western Reserve University and Case Comprehensive Cancer Center/University Hospitals Case Medical Center, Cleveland, Ohio 44106-6068, USA.
Abstract:
Human DNA mismatch repair (MMR) is involved in the response to certain chemotherapy drugs, including 6-thioguanine (6-TG). Consistently, MMR-deficient human tumor cells show resistance to 6-TG damage as manifested by a reduced G(2)-M arrest and decreased apoptosis. In this study, we investigate the role of the BRCA1 protein in modulating a 6-TG-induced MMR damage response, using an isogenic human breast cancer cell line model, including a BRCA1 mutated cell line (HCC1937) and its transfectant with a wild-type BRCA1 cDNA. The MMR proteins MSH2, MSH6, MLH1, and PMS2 are similarly detected in both cell lines. BRCA1-mutant cells are more resistant to 6-TG than BRCA1-positive cells in a clonogenic survival assay and show reduced apoptosis. Additionally, the mutated BRCA1 results in an almost complete loss of a G(2)-M cell cycle checkpoint response induced by 6-TG. Transfection of single specific small interfering RNAs (siRNA) against MSH2, MLH1, ATR, and Chk1 in BRCA1-positive cells markedly reduces the BRCA1-dependent G(2)-M checkpoint response. Interestingly, ATR and Chk1 siRNA transfection in BRCA1-positive cells shows similar levels of 6-TG cytotoxicity as the control transfectant, whereas MSH2 and MLH1 siRNA transfectants show 6-TG resistance as expected. DNA MMR processing, as measured by the number of 6-TG-induced DNA strand breaks using an alkaline comet assay (+/-z-VAD-fmk cotreatment) and by levels of iododeoxyuridine-DNA incorporation, is independent of BRCA1, suggesting the involvement of BRCA1 in the G(2)-M checkpoint response to 6-TG but not in the subsequent excision processing of 6-TG mispairs by MMR.
Insights
BRCA1 mutations impair the DNA damage response to 6-thioguanine (6-TG), reducing cell cycle arrest and apoptosis. BRCA1 influences the G(2)-M checkpoint but not the mismatch repair (MMR) processing of 6-TG-induced DNA damage.
Area of Science:
- Molecular Biology
- Cancer Research
- DNA Repair
Background:
- Human DNA mismatch repair (MMR) is crucial for responding to chemotherapy agents like 6-thioguanine (6-TG).
- MMR-deficient cells exhibit resistance to 6-TG, characterized by reduced G(2)-M arrest and apoptosis.
Purpose of the Study:
- To investigate the role of BRCA1 in modulating the 6-TG-induced MMR damage response.
- To compare 6-TG sensitivity and DNA damage response in BRCA1-mutant versus BRCA1-positive human breast cancer cells.
Main Methods:
- Utilized an isogenic human breast cancer cell line model (BRCA1-mutant HCC1937 and its wild-type BRCA1 transfectant).
- Assessed clonogenic survival, apoptosis, and G(2)-M cell cycle checkpoint response.
- Employed small interfering RNA (siRNA) to target MMR and checkpoint proteins (MSH2, MLH1, ATR, Chk1).
- Measured DNA strand breaks (alkaline comet assay) and DNA incorporation (iododeoxyuridine).
Main Results:
- BRCA1-mutant cells demonstrated increased resistance to 6-TG, reduced apoptosis, and a near-complete loss of the 6-TG-induced G(2)-M checkpoint.
- siRNA targeting MSH2 or MLH1 in BRCA1-positive cells mimicked 6-TG resistance, while ATR/Chk1 siRNA reduced the BRCA1-dependent G(2)-M checkpoint.
- DNA MMR processing, indicated by DNA strand breaks and incorporation, was independent of BRCA1 status.
Conclusions:
- BRCA1 plays a significant role in the G(2)-M checkpoint response to 6-TG-induced DNA damage.
- BRCA1 is not directly involved in the excision processing of 6-TG mispairs by the MMR system.
- These findings highlight BRCA1's function in DNA damage signaling pathways distinct from its role in MMR excision repair.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

